Kristin Hart, CPC, CHONC
Consultant working with biopharmaceutical companies to create meaningful solutions that successfully support patient access to therapies for oncology and rare diseases.
DK Pierce (DKP) has been blazing trails in market access and reimbursement for over two decades. We provide strategic and tactical services spanning entire product lifecycles with a focus on oncology, rare diseases, and cell and gene therapies. Our seasoned specialists excel at anticipating, monitoring, and effectively interpreting the biopharma space. As a nimble, employee-owned company, DKP offers unparalleled expertise with an unexpected personal touch. From our clients, team, and partners, to the patients we want to see thrive, we’re a people-first consulting firm. Partnering with us means partnering with true specialists—not generalists—who dig deep and provide trusted guidance and actionable insights.
